These compounds were evaluated to determine their potential ligand binding affinity toward established anti-DM and COVID-19 targets, specifically α-glucosidase, α-amylase, ACE2, and TMPRSS2. The gene discussed is TMPRSS2; the disease is diabetes mellitus.